Skip to main content

Advertisement

Contact Mathias Lühr Hansen

From: Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial

Contact corresponding author